InvestorPlace Research Staff

Recent Articles

The Red Ink on Novavax Only Hides Its True Potential

As rival coronavirus vaccines generate exciting headlines, NVAX stock has fallen out of favor with Wall Street. However, this is a mistake as Novavax’s vaccine candidate offers a superior holistic solution.

Good News at the Same Price Makes Penn National a Buy

PENN stock has stagnated for two months now, but promising election results and solid earnings have only strengthened the bull case.

Seize the Opportunity and Buy Delta Stock Before It’s Clear Skies Ahead

Uncertainty continues, but now's the time to buy DAL stock, ahead of what could be a multi-year return to the "old normal."

Next-Generation Batteries Are the New Hottest Investment

Without better battery technology, it will be difficult -- if not impossible -- for EVs to replace gas-powered vehicles. And solid state batteries look to be the big winner in this space.

MoneyLine Podcast: Small Caps Are Joining the Rally — Why That’s HUGE News

In today's MoneyLine podcast, Matt McCall explains the importance of the small-cap breakout, answers your investment questions and shares how to profit in today's stock market.